GlaxoSmithkline Consumer Healthcare Ltd.

BSE: 500676
₹10753.65
▲ 521.30 (5.09%)
April 15, 2020 · BSE · bse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
88/100
Bullish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
56.8
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
Data unavailable.
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Ownership

2 of 2 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter

Value and momentum

3 of 4 met
  • Yes Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
5.1%
Low 10394.0500 · High 10845.7500
1W return
1.3%
Low 10123.8500 · High 10845.7500
1M return
27.9%
Low 7696.2500 · High 11290.0000
52W return
49.0%
Low 6905.0000 · High 11290.0000
Lifetime High ₹10753.6500 (April 15, 2020)
Lifetime Low ₹490.0500 (Dec. 1, 2008)

Full price history and technicals →

EMA & SMA

Bullish6
Bearish0
5D
10387.1
10D
10079.1
20D
9733.0
50D
9394.3
100D
9084.3
200D
8576.1

Delivery and volume

Day avg. delivery
56.1%
Week avg. delivery
50.0%
Month avg. delivery
45.7%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

10664.48
Pivot
First resistance10934.92
Second resistance11116.18
Third resistance11386.62
First support10483.22
Second support10212.78
Third support10031.52
Day RSI62.8
Day MFI72.6
Day MACD356.35
Day MACD signal192.61

Beta

1M0.86
3M0.78
1Y0.74
3Y0.65

Price change analysis

↑ 27.9%
Over 1 Month
LowHigh
7696.2511290.00
↑ 22.7%
Over 3 Months
LowHigh
7500.0011290.00
↑ 22.1%
Over 6 Months
LowHigh
7500.0011290.00
↑ 49.0%
Over 1 Year
LowHigh
6905.0011290.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Data unavailable.

Shareholding pattern / Ownership

Shareholding summary

Dec 2019
  • Promoter72.46%
  • Mutual funds3.68%
  • FII/FPI4.58%

Largest holders

NameCategoryShares %Shares
HORLICKS LIMITEDPromoter43.1600%18152243
GLAXOSMITHKLINE PTE LIMITEDPromoter29.2900%12319749
LICI NEW ENDOWMENT PLUS-BALANCED FUNDPublic2.6700%1121107
Qualified Institutional BuyerPublic1.9100%803763
NON RESIDENT INDIAN NON REPATRIABLEPublic0.2600%108505

As of Dec. 31, 2019. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 72.46% in Dec 2019 qtr

Historical fii holding

FII/FPI holdings increased from 4.37% to 4.58% in Dec 2019 qtr

Historical mutual fund holding

Mutual funds holdings decreased from 4.03% to 3.68% in Dec 2019 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
24 Sep 2009 ARISAIG INDIA FUND LTD Bulk Buy 300,000 1149.9600 BSE
26 Aug 2004 CAPITAL INTERNATIONAL Bulk Sell 1,577,061 225.0000 BSE
26 Aug 2004 T ROWE PRICE INTERNATIONA Bulk Buy 1,577,061 225.0000 BSE

All bulk and block deals →

Last 12 months ₹105.00 per share
Dividend yield 0.98%
Ex-dateSubjectPer share (₹)Record date
25 Jul 2019 Annual General Meeting/Dividend - Rs 105 Per Share 105.0000 —
31 Jul 2018 Annual General Meeting / Dividend- Rs 75 Per Share 75.0000 —
2 Aug 2017 Annual General Meeting/Dividend - Rs 70/- Per Share 70.0000 —
26 Jul 2016 Annual General Meeting/ Dividend - Rs 70/- Per Share 70.0000 —
27 Jul 2015 Annual General Meeting/Dividend - Rs. 55/- Per Share 55.0000 —
28 Jul 2014 Annual General Meeting / Dividend - Rs 45/- Per Share (Bc Start Date Revised) 45.0000 —
19 Mar 2013 Annual General Meeting/Dividend Rs 45 Per Share 45.0000 —
9 Mar 2012 Annual General Meeting And Dividend Rs.35/- Per Share 35.0000 —
11 Mar 2011 Annual General Meeting And Dividend Rs.50/- Per Share (Special Dividend Rs.25/- Per Share And Final Dividend Rs.25/- Per Share) 50.0000 —

Corporate Actions

Full history (18 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Smithkline Beecham Consumer Healthc to GlaxoSmithkline Consumer Healthcare Ltd.
9 Apr 2010AGMAgm/Div-Rs.18/- Per Share
13 Apr 2009AGMAgm/Div-Rs.5 Per Share
29 Oct 2008OTHERInt Div - Rs. 10/- Per Shpurpose Revised
15 Apr 2008OTHERAnnual General Meeting

All corporate actions →

Corporate Announcements

All 210 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
8 Apr 2020 Suspension of Trading GSKCONS: Members of the Exchange are hereby informed that the trading in Equity Shares of GlaxoSmithKline Consumer Healthcare Limited shall be suspended w.e.f. April 16, 2020 (i.e. closing hours of trading on April 15, 2020) on account of Scheme of Amalgamation with Hindustan Unilever Limited.
1 Apr 2020 Record Date GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Intimation of Record Date and Effective Date for Scheme of Amalgamation by way of merger by absorption among GlaxoSmithKline Consumer Healthcare Limited and Hindustan Unilever Limited and their respective shareholders and creditors.
13 Mar 2020 Scheme of Arrangement GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange about Scheme of Arrangement
26 Feb 2020 Amalgamation/Merger Update on Scheme of amalgamation and arrangement between GlaxoSmithKline Consumer Healthcare Limited and Hindustan Unilever Limited and their respective shareholders and creditors
6 Feb 2020 Financial Result Updates GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange, the financial results for the period ended December 31, 2019.
6 Feb 2020 Outcome of Board Meeting GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Board meeting held on February 06, 2020.
3 Feb 2020 Analysts/Institutional Investor Meet/Con. Call Updates GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
13 Jan 2020 Registrar & Share Transfer Agent Update GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Registrar & Share Transfer Agent Update
17 Dec 2019 Related Party Transactions GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange Related Party Transactions, drawn in accordance with applicable accounting standards.
2 Dec 2019 Trading Window GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about GlaxoSmithkline Consumer Healthcare Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.